Plasma concentrations of soluble TNF-alpha receptors in obese subjects

International Journal of Obesity

Volumn 22, Issue 12, 1998, Pages 1239-1243

  Hauner, H ^a   Bender, M ^a   Haastert, B ^a   Hube, F ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Obesity; Soluble TNF receptors; TNF ; Type 2 diabetes mellitus

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD LEVEL; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; INSULIN RESISTANCE; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0031793066     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800773     Document Type: Article

References (26)

1. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-χ: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
2. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-2119.
3. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor-necrosis factor-χ in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
4. Hotamisligil GS, Spiegelman BM. TNF-χ. A key component of the obesity-diabetes link. Diabetes 1994; 43: 1271-1278.
5. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-χ suppresses insulin-induced tyrosine phosphorylation of the insulin receptor and its substrates. J Biol Chem 1993; 268: 26055-26058.
6. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor-χ inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994; 91: 4854-4858.
7. Kroder G, Bossenmayer B, Kellerer M, Capp E, Stoyanov B, Mühlhofer A, Berti L, Horikoshi H, Ullrich A, Häring HU. Tumor necrosis factor-χ and hyperglycemia-induced insulin resistance. J Clin Invest 1996; 97: 1471-1477.
8. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance. Science 1996; 271: 665-668.
9. Liu LS, Spelleken M, Röhrig K, Hauner H, Eckel J. Tumor necrosis factor (TNF)-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 TNF receptor. Diabetes 1998; 47: 515-522.
10. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996; 45: 881-885.
11. Frittitta L, Youngren JF, Sbraccia P, D'Adamo M, Buongiorno A, Vigneri R, Goldfine ID, Trischitta V. Increased adipose tissue PC-I protein content, but not tumour necrosis factor-α gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia 1997; 40: 282-289.
12. Petruschke T, Hauner H. Tumor Necrosis Factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J Clin Endocrinol Metab 1993; 76: 742-747.
13. Hauner H, Petruschke T, Russ M, Röhrig K, Eckel J. Effects of Tumor Necrosis Factor alpha (TNF) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 1995; 38: 764-771.
14. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 1997; 46: 451-455.
15. Hube F, Röhrig K, Hauner H. Overexpression of both TNF receptors in human obesity. Int J Obes 1997; 21 (Suppl 2): S130.
16. Pinckard JK, Sheehan KC, Arthur CD, Schreiber RD. Constitutive shedding of both p55 and p75 murine TNF receptors in vivo. J Immunol 1997; 158: 3869-3873.
17. World Health Organization. Diabetes mellitus. Report of a WHO Study Group. WHO: Geneva, 1985.
18. Aggarwal BB, Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Net 1996; 7: 93-124.
19. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-χ in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
20. Pfeiffer A, Janott J, Möhlig M, Ristow M, Rochlitz H, Busch K, Schatz H, Schifferdecker E. Circulating tumor necrosis factor a is elevated in male but not in female patients with type 11 diabetes mellitus. Horm Metab Res 1997; 29: 111-114.
21. Grunfeld C, Feingold KR. The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 1991; 3: 143-158.
22. Starnes HF, Warren RS, Jeevanandam M, Gabrilove JL, Larchian W, Oettgen HF, Brennan MF. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest 1988; 82: 1321-1326.
23. Kellerer M, Rett K, Renn W, Groop L, Häring HU. Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity. Horm Metab Res 1996; 28: 737-743.
24. Trefzer U, Brockhaus M, Loetscher H, Parlow F, Budnik A, Grewe M, Christoph H, Kapp A, Schöpf E, Luger TA, Krutmann J. The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. J Clin Invest 1993; 92: 462-470.
25. Winzen R, Wallach D, Kemper O, Resch K, Holtmann H. Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J Immunol 1993; 150: 4346-4353.
26. Crowe PD, Walter BN, Mohler KM, Otten-Evans C, Black RA, Ware CF. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med 1995; 181: 1205-1210.